OPKO HEALTH,INC. (OPK)
BioReference® Launches BioReference DirectTM, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
BioReference® Launches BioReference DirectTM, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical